Iovance Biotherapeutics
IOVA
IOVA
82 hedge funds and large institutions have $271M invested in Iovance Biotherapeutics in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 80 → 82 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
82
Holding in Top 10
2
Calls
$6.39M
Puts
$215K
Top Buyers
| 1 | +$4.68M | |
| 2 | +$4.63M | |
| 3 | +$2.37M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.15M |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$711K |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$2.25M | |
| 3 | -$1.73M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.4M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$835K |